Outcomes of Sepsis Patients in China (CHINA-SEP)

NCT07066553 · tracked via the Priya Life Science China tracker

Sponsor

Southeast University, China

Phase

Observational

Started

2025-07-18

Last updated

2025-07-15

Condition(s) studied

Sepsis

Study summary

Sepsis poses a significant public health challenge in China. However, longitudinal real-world evidence on guideline adherence and patient outcomes remains scarce. This registry aims to address these gaps by systematically capturing guideline-concordant treatment patterns and associated outcomes in ICU patients diagnosed according to Sepsis-3.0 criteria across diverse settings, thereby generating actionable evidence to improve the quality of sepsis care nationwide.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Hospitalized patients aged ≥18 years * Sepsis diagnosis meeting Sepsis-3 criteria * Informed consent signed by patient or legally authorized representative Exclusion Criteria: * Patients with a prior history of sepsis * Sepsis diagnosis \>48 hours prior to enrollment * Current participation in clinical trial

Primary outcome measure(s)

28-day all-cause mortality — 28 days after enrollment.

Trial sites (1)

Facility	City	Region	Status
Zhongda hospital, Southeast University	Nanjing	Jiangsu

More Southeast University, China trials in China

The Physiological Effect of RCexp on Ventilation/Perfusion Distribution Recruiting

Inhaled Colistin to Prevent Ventilator-Associated Pneumonia in Patients With Acute Brain Injury Recruiting

Effect of Xuebijing InjecTion on Outcomes in Sepsis Patients Under Real-World Conditions（EXIT-SEP REAL） Starting soon

Validation and Precision Treatment of Inflammatory Subphenotypes in Acute Respiratory Distress Syndrome: A Multicenter Cohort Study Recruiting

Effect of Early Transition to Assisted Ventilation on 28-day Successful Extubation in Critically Ill Patients Recruiting

Other trials for the same condition

PyroEVs/PLIN3 Mediate Lipid Droplet-Mitochondrial Coupling in Sepsis Endothelial Injury Recruiting

PCT Guided Antibiotics Use in Critically Ill Adult Patients in China Starting soon

Detection of Sepsis Occurrence by Using Blood Fluorescence Recruiting

Evaluating the Diagnostic Performance and Impact on Clinical Outcomes of the NuRapid-CRISPR Pathogen Profile Assay in ICU Patients With Sepsis Starting soon

Postoperative Infections and Immune Profiles in Patients Undergoing LVAD Implantation Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07066553 on ClinicalTrials.gov ↗ ← All trials in China